Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 1
Submit an article Journal homepage
423
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Frequent mutations in HLA and related genes in extranodal NK/T cell lymphomas

Chantana Polpraserta Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand;b Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, ThailandView further author information
,
Yasuhide Takeuchic Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan;d Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan;e Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, JapanView further author information
,
Hideki Makishimac Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan;e Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, JapanView further author information
,
Kitsada Wudhikarna Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand;b Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, ThailandView further author information
,
Nobuyuki Kakiuchic Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan;e Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, JapanView further author information
,
Nichthida Tangnuntachaif Department of Pathology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, ThailandView further author information
,
Thamathorn Assanasenf Department of Pathology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, ThailandView further author information
,
Wimonmas Sitthif Department of Pathology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, ThailandView further author information
,
Hamidah Muhamada Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, ThailandView further author information
,
Panisinee Lawasuta Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand;b Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, ThailandView further author information
,
Sunisa Kongkiatkamona Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand;b Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, ThailandView further author information
,
Udomsak Bunworasatea Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand;b Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, ThailandView further author information
,
Koji Izutsug Department of Hematology, Toranomon Hospital, Tokyo, JapanView further author information
,
Yuichi Shiraishih Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, JapanView further author information
,
Kenichi Chibah Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, JapanView further author information
,
Hiroko Tanakah Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, JapanView further author information
,
Satoru Miyanoh Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0002-1753-6616View further author information
ORCID Icon,
Seishi Ogawac Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan;e Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan;i Department of Medicine, Centre for Haematology and Regenerative Medicine, Karolinska Institute, Stockholm, SwedenCorrespondence[email protected]
View further author information
,
Kenichi Yoshidac Department of Pathology and Tumor Biology, Kyoto University, Kyoto, JapanCorrespondence[email protected]
View further author information
&
Ponlapat Rojnuckarina Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand;b Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, ThailandCorrespondence[email protected] [email protected]
View further author information
 show all
Pages 95-103 | Received 06 Aug 2020, Accepted 29 Aug 2020, Published online: 23 Sep 2020

References

  • Yamaguchi M, Kwong YL, Kim WS, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol. 2011;29(33):4410–4416.
  • de Mel S, Hue SSS, Jeyasekharan AD, et al. Molecular pathogenic pathways in extranodal NK/T cell lymphoma. J Hematol Oncol. 2019;12(1):33.
  • Li Z, Xia Y, Feng LN, et al. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study. Lancet Oncol. 2016;17(9):1240–1247.
  • Kanno H, Kojya S, Li T, et al. Low frequency of HLA-A*0201 allele in patients with Epstein-Barr virus-positive nasal lymphomas with polymorphic reticulosis morphology. Int J Cancer. 2000;87(2):195–199.
  • Campoli M, Ferrone S. HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance. Oncogene. 2008;27(45):5869–5885.
  • Kataoka K, Nagata Y, Kitanaka A, et al. Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat Genet. 2015;47(11):1304–1315.
  • Shiraishi Y, Sato Y, Chiba K, et al. An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data. Nucleic Acids Res. 2013;41(7):e89.
  • Robinson JT, Thorvaldsdottir H, Winckler W, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29(1):24–26.
  • Jiang L, Gu ZH, Yan ZX, et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma. Nat Genet. 2015;47(9):1061–1066.
  • Yokoyama A, Kakiuchi N, Yoshizato T, et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature. 2019;565(7739):312–317.
  • Drénou B, Tilanus M, Semana G, et al. Loss of heterozygosity, a frequent but a non-exclusive mechanism responsible for HLA dysregulation in non-Hodgkin's lymphomas. Br J Haematol. 2004;127(1):40–49.
  • Muhamad H, Suksawai N, Assanasen T, et al. Programmed cell death 1 and programmed cell death ligands in extranodal natural killer/T cell lymphoma: expression pattern and potential prognostic relevance. Acta Haematol. 2020;143(1):78–88.
  • Yamaguchi M, Tobinai K, Oguchi M, et al. Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211. J Clin Oncol. 2012;30(32):4044–4046.
  • Arthur SE, Jiang A, Grande BM, et al. Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma. Nat Commun. 2018;9(1):4001.
  • Okuno Y, Murata T, Sato Y, et al. Defective Epstein-Barr virus in chronic active infection and haematological malignancy. Nat Microbiol. 2019;4(3):404–413.
  • Shiraishi Y, Tremmel G, Miyano S, et al. A simple model-based approach to inferring and visualizing cancer mutation signatures. PLoS Genet. 2015;11(12):e1005657.
  • Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer. Nature. 2013;500(7463):415–421.
  • Pich O, Muiños F, Lolkema MP, et al. The mutational footprints of cancer therapies. Nat Genet. 2019;51(12):1732–1740.
  • Martincorena I, Raine KM, Gerstung M, et al. Universal patterns of selection in cancer and somatic tissues. Cell. 2017;171(5):1029–1041.
  • McGranahan N, Rosenthal R, Hiley CT, et al. Allele-Specific HLA loss and immune escape in lung cancer evolution. Cell. 2017;171(6):1259–1271.
  • Lee S, Park HY, Kang SY, et al. Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type. Oncotarget. 2015;6(19):17764–17776.
  • Zhang Y, Li C, Xue W, et al. Frequent mutations in natural killer/T cell lymphoma. Cell Physiol Biochem. 2018;49(1):1–16.
  • Cai L, Michelakos T, Yamada T, et al. Defective HLA class I antigen processing machinery in cancer. Cancer Immunol Immunother. 2018;67(6):999–1009.
  • Kataoka K, Miyoshi H, Sakata S, et al. Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas. Leukemia. 2019;33(7):1687–1699.
  • Jaiswal S, Fontanillas P, Flannick J, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488–2498.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.